HEADER MEMBRANE PROTEIN 11-JUL-17 5WF6 TITLE AGONIST BOUND HUMAN A2A ADENOSINE RECEPTOR WITH S91A MUTATION AT 2.90 TITLE 2 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN A2A ADENOSINE RECEPTOR T4L CHIMERA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LYSIS PROTEIN,LYSOZYME,MURAMIDASE; COMPND 5 EC: 3.2.1.17; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: S91A MUTATION SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 10665; SOURCE 5 GENE: ADORA2A, ADORA2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9 KEYWDS HUMAN A2A ADENOSINE RECEPTOR, S91A, GPCR-T4L CHIMERA, MEMBRANE KEYWDS 2 PROTEIN, LCP, AGONIST, UK432097, ACTIVATION MICROSWITCH, ALLOSTERIC KEYWDS 3 NA-SITE MUTANT, GPCR SIGNALING EXPDTA X-RAY DIFFRACTION AUTHOR K.L.WHITE,M.T.EDDY,Z.GAO,G.W.HAN,M.A.HANSON,T.LIAN,A.DEARY,N.PATEL, AUTHOR 2 K.A.JACOBSON,V.KATRITCH,R.C.STEVENS REVDAT 3 16-OCT-24 5WF6 1 REMARK REVDAT 2 04-OCT-23 5WF6 1 REMARK REVDAT 1 21-FEB-18 5WF6 0 JRNL AUTH K.L.WHITE,M.T.EDDY,Z.G.GAO,G.W.HAN,T.LIAN,A.DEARY,N.PATEL, JRNL AUTH 2 K.A.JACOBSON,V.KATRITCH,R.C.STEVENS JRNL TITL STRUCTURAL CONNECTION BETWEEN ACTIVATION MICROSWITCH AND JRNL TITL 2 ALLOSTERIC SODIUM SITE IN GPCR SIGNALING. JRNL REF STRUCTURE V. 26 259 2018 JRNL REFN ISSN 1878-4186 JRNL PMID 29395784 JRNL DOI 10.1016/J.STR.2017.12.013 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (DEV_2614: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.49 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.8 REMARK 3 NUMBER OF REFLECTIONS : 12850 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.254 REMARK 3 R VALUE (WORKING SET) : 0.253 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 660 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.4885 - 4.9530 0.96 2596 149 0.2275 0.2600 REMARK 3 2 4.9530 - 3.9343 0.96 2510 151 0.2547 0.2980 REMARK 3 3 3.9343 - 3.4378 0.97 2557 130 0.2670 0.2983 REMARK 3 4 3.4378 - 3.1239 0.93 2454 135 0.3025 0.3760 REMARK 3 5 3.1239 - 2.9002 0.78 2073 95 0.3358 0.3387 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.430 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 37.150 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3554 REMARK 3 ANGLE : 0.483 4844 REMARK 3 CHIRALITY : 0.037 572 REMARK 3 PLANARITY : 0.003 632 REMARK 3 DIHEDRAL : 14.369 2110 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5WF6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUL-17. REMARK 100 THE DEPOSITION ID IS D_1000228876. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-FEB-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13000 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 44.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.9 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.21800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.71000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB 3EML REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM CITRATE PH 5, 24-27% REMARK 280 (V/V) POLYETHYLENE GLYCOL (PEG) 400, 30-80 MM MGCL 2 , 5% (V/V) REMARK 280 JEFFAMINE M-600 PH 7 (HAMPTON), LIPIDIC CUBIC PHASE, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.11300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE BIOLOGICAL UNIT IS UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -30 REMARK 465 LYS A -29 REMARK 465 THR A -28 REMARK 465 ILE A -27 REMARK 465 ILE A -26 REMARK 465 ALA A -25 REMARK 465 LEU A -24 REMARK 465 SER A -23 REMARK 465 TYR A -22 REMARK 465 ILE A -21 REMARK 465 PHE A -20 REMARK 465 CYS A -19 REMARK 465 LEU A -18 REMARK 465 VAL A -17 REMARK 465 PHE A -16 REMARK 465 ALA A -15 REMARK 465 ASP A -14 REMARK 465 TYR A -13 REMARK 465 LYS A -12 REMARK 465 ASP A -11 REMARK 465 ASP A -10 REMARK 465 ASP A -9 REMARK 465 ASP A -8 REMARK 465 ALA A -7 REMARK 465 MET A -6 REMARK 465 GLY A -5 REMARK 465 GLN A -4 REMARK 465 PRO A -3 REMARK 465 VAL A -2 REMARK 465 GLY A -1 REMARK 465 ALA A 0 REMARK 465 PRO A 1 REMARK 465 PRO A 2 REMARK 465 GLY A 147 REMARK 465 GLN A 148 REMARK 465 PRO A 149 REMARK 465 LYS A 150 REMARK 465 GLU A 151 REMARK 465 GLY A 152 REMARK 465 LYS A 153 REMARK 465 ASN A 154 REMARK 465 HIS A 155 REMARK 465 SER A 156 REMARK 465 GLN A 157 REMARK 465 LEU A 308 REMARK 465 ARG A 309 REMARK 465 GLN A 310 REMARK 465 GLN A 311 REMARK 465 GLU A 312 REMARK 465 PRO A 313 REMARK 465 PHE A 314 REMARK 465 LYS A 315 REMARK 465 ALA A 316 REMARK 465 HIS A 317 REMARK 465 HIS A 318 REMARK 465 HIS A 319 REMARK 465 HIS A 320 REMARK 465 HIS A 321 REMARK 465 HIS A 322 REMARK 465 HIS A 323 REMARK 465 HIS A 324 REMARK 465 HIS A 325 REMARK 465 HIS A 326 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 4 CG SD CE REMARK 470 TYR A 43 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 120 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 141 CG CD1 CD2 REMARK 470 VAL A 164 CG1 CG2 REMARK 470 LYS A1016 CG CD CE NZ REMARK 470 LYS A1060 CG CD CE NZ REMARK 470 ARG A1080 CD NE CZ NH1 NH2 REMARK 470 LYS A1083 CG CD CE NZ REMARK 470 GLN A1123 CG CD OE1 NE2 REMARK 470 LYS A1135 CD CE NZ REMARK 470 ARG A1137 NE CZ NH1 NH2 REMARK 470 LYS A 227 CG CD CE NZ REMARK 470 LYS A 233 CD CE NZ REMARK 470 ASP A 261 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG1 THR A 41 NH1 ARG A 102 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A1020 -166.62 -68.76 REMARK 500 THR A1034 145.08 -171.25 REMARK 500 ASN A1055 15.93 59.66 REMARK 500 HIS A 264 151.86 -49.75 REMARK 500 TRP A 268 -37.13 -39.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLC A 1202 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue UKA A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1202 DBREF 5WF6 A 2 208 UNP P29274 AA2AR_HUMAN 2 208 DBREF 5WF6 A 1002 1161 UNP P00720 ENLYS_BPT4 2 161 DBREF 5WF6 A 222 316 UNP P29274 AA2AR_HUMAN 222 316 SEQADV 5WF6 MET A -30 UNP P29274 INITIATING METHIONINE SEQADV 5WF6 LYS A -29 UNP P29274 EXPRESSION TAG SEQADV 5WF6 THR A -28 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ILE A -27 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ILE A -26 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ALA A -25 UNP P29274 EXPRESSION TAG SEQADV 5WF6 LEU A -24 UNP P29274 EXPRESSION TAG SEQADV 5WF6 SER A -23 UNP P29274 EXPRESSION TAG SEQADV 5WF6 TYR A -22 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ILE A -21 UNP P29274 EXPRESSION TAG SEQADV 5WF6 PHE A -20 UNP P29274 EXPRESSION TAG SEQADV 5WF6 CYS A -19 UNP P29274 EXPRESSION TAG SEQADV 5WF6 LEU A -18 UNP P29274 EXPRESSION TAG SEQADV 5WF6 VAL A -17 UNP P29274 EXPRESSION TAG SEQADV 5WF6 PHE A -16 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ALA A -15 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ASP A -14 UNP P29274 EXPRESSION TAG SEQADV 5WF6 TYR A -13 UNP P29274 EXPRESSION TAG SEQADV 5WF6 LYS A -12 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ASP A -11 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ASP A -10 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ASP A -9 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ASP A -8 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ALA A -7 UNP P29274 EXPRESSION TAG SEQADV 5WF6 MET A -6 UNP P29274 EXPRESSION TAG SEQADV 5WF6 GLY A -5 UNP P29274 EXPRESSION TAG SEQADV 5WF6 GLN A -4 UNP P29274 EXPRESSION TAG SEQADV 5WF6 PRO A -3 UNP P29274 EXPRESSION TAG SEQADV 5WF6 VAL A -2 UNP P29274 EXPRESSION TAG SEQADV 5WF6 GLY A -1 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ALA A 0 UNP P29274 EXPRESSION TAG SEQADV 5WF6 PRO A 1 UNP P29274 EXPRESSION TAG SEQADV 5WF6 ALA A 91 UNP P29274 SER 91 ENGINEERED MUTATION SEQADV 5WF6 GLY A 1012 UNP P00720 ARG 12 ENGINEERED MUTATION SEQADV 5WF6 THR A 1054 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 5WF6 ALA A 1097 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 5WF6 ARG A 1137 UNP P00720 ILE 137 ENGINEERED MUTATION SEQADV 5WF6 HIS A 317 UNP P29274 EXPRESSION TAG SEQADV 5WF6 HIS A 318 UNP P29274 EXPRESSION TAG SEQADV 5WF6 HIS A 319 UNP P29274 EXPRESSION TAG SEQADV 5WF6 HIS A 320 UNP P29274 EXPRESSION TAG SEQADV 5WF6 HIS A 321 UNP P29274 EXPRESSION TAG SEQADV 5WF6 HIS A 322 UNP P29274 EXPRESSION TAG SEQADV 5WF6 HIS A 323 UNP P29274 EXPRESSION TAG SEQADV 5WF6 HIS A 324 UNP P29274 EXPRESSION TAG SEQADV 5WF6 HIS A 325 UNP P29274 EXPRESSION TAG SEQADV 5WF6 HIS A 326 UNP P29274 EXPRESSION TAG SEQRES 1 A 504 MET LYS THR ILE ILE ALA LEU SER TYR ILE PHE CYS LEU SEQRES 2 A 504 VAL PHE ALA ASP TYR LYS ASP ASP ASP ASP ALA MET GLY SEQRES 3 A 504 GLN PRO VAL GLY ALA PRO PRO ILE MET GLY SER SER VAL SEQRES 4 A 504 TYR ILE THR VAL GLU LEU ALA ILE ALA VAL LEU ALA ILE SEQRES 5 A 504 LEU GLY ASN VAL LEU VAL CYS TRP ALA VAL TRP LEU ASN SEQRES 6 A 504 SER ASN LEU GLN ASN VAL THR ASN TYR PHE VAL VAL SER SEQRES 7 A 504 LEU ALA ALA ALA ASP ILE ALA VAL GLY VAL LEU ALA ILE SEQRES 8 A 504 PRO PHE ALA ILE THR ILE SER THR GLY PHE CYS ALA ALA SEQRES 9 A 504 CYS HIS GLY CYS LEU PHE ILE ALA CYS PHE VAL LEU VAL SEQRES 10 A 504 LEU THR GLN SER ALA ILE PHE SER LEU LEU ALA ILE ALA SEQRES 11 A 504 ILE ASP ARG TYR ILE ALA ILE ARG ILE PRO LEU ARG TYR SEQRES 12 A 504 ASN GLY LEU VAL THR GLY THR ARG ALA LYS GLY ILE ILE SEQRES 13 A 504 ALA ILE CYS TRP VAL LEU SER PHE ALA ILE GLY LEU THR SEQRES 14 A 504 PRO MET LEU GLY TRP ASN ASN CYS GLY GLN PRO LYS GLU SEQRES 15 A 504 GLY LYS ASN HIS SER GLN GLY CYS GLY GLU GLY GLN VAL SEQRES 16 A 504 ALA CYS LEU PHE GLU ASP VAL VAL PRO MET ASN TYR MET SEQRES 17 A 504 VAL TYR PHE ASN PHE PHE ALA CYS VAL LEU VAL PRO LEU SEQRES 18 A 504 LEU LEU MET LEU GLY VAL TYR LEU ARG ILE PHE LEU ALA SEQRES 19 A 504 ALA ARG ARG GLN LEU ASN ILE PHE GLU MET LEU ARG ILE SEQRES 20 A 504 ASP GLU GLY LEU ARG LEU LYS ILE TYR LYS ASP THR GLU SEQRES 21 A 504 GLY TYR TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SEQRES 22 A 504 SER PRO SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS SEQRES 23 A 504 ALA ILE GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP SEQRES 24 A 504 GLU ALA GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA SEQRES 25 A 504 VAL ARG GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL SEQRES 26 A 504 TYR ASP SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE SEQRES 27 A 504 ASN MET VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY SEQRES 28 A 504 PHE THR ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP SEQRES 29 A 504 ASP GLU ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR SEQRES 30 A 504 ASN GLN THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR SEQRES 31 A 504 PHE ARG THR GLY THR TRP ASP ALA TYR ARG SER THR LEU SEQRES 32 A 504 GLN LYS GLU VAL HIS ALA ALA LYS SER LEU ALA ILE ILE SEQRES 33 A 504 VAL GLY LEU PHE ALA LEU CYS TRP LEU PRO LEU HIS ILE SEQRES 34 A 504 ILE ASN CYS PHE THR PHE PHE CYS PRO ASP CYS SER HIS SEQRES 35 A 504 ALA PRO LEU TRP LEU MET TYR LEU ALA ILE VAL LEU SER SEQRES 36 A 504 HIS THR ASN SER VAL VAL ASN PRO PHE ILE TYR ALA TYR SEQRES 37 A 504 ARG ILE ARG GLU PHE ARG GLN THR PHE ARG LYS ILE ILE SEQRES 38 A 504 ARG SER HIS VAL LEU ARG GLN GLN GLU PRO PHE LYS ALA SEQRES 39 A 504 HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS HET UKA A1201 57 HET OLC A1202 9 HETNAM UKA 6-(2,2-DIPHENYLETHYLAMINO)-9-[(2R,3R,4S,5S)-5- HETNAM 2 UKA (ETHYLCARBAMOYL)-3,4-DIHYDROXY-OXOLAN-2-YL]-N-[2-[(1- HETNAM 3 UKA PYRIDIN-2-YLPIPERIDIN-4-YL) HETNAM 4 UKA CARBAMOYLAMINO]ETHYL]PURINE-2-CARBOXAMIDE HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 UKA C40 H47 N11 O6 FORMUL 3 OLC C21 H40 O4 FORMUL 4 HOH *2(H2 O) HELIX 1 AA1 MET A 4 ASN A 34 1 31 HELIX 2 AA2 SER A 35 GLN A 38 5 4 HELIX 3 AA3 ASN A 39 LEU A 58 1 20 HELIX 4 AA4 LEU A 58 ILE A 66 1 9 HELIX 5 AA5 ALA A 73 ILE A 108 1 36 HELIX 6 AA6 ARG A 111 VAL A 116 1 6 HELIX 7 AA7 THR A 117 LEU A 137 1 21 HELIX 8 AA8 THR A 138 GLY A 142 5 5 HELIX 9 AA9 LEU A 167 VAL A 172 1 6 HELIX 10 AB1 PRO A 173 TYR A 179 1 7 HELIX 11 AB2 PHE A 180 VAL A 186 1 7 HELIX 12 AB3 VAL A 186 ARG A 205 1 20 HELIX 13 AB4 ASN A 1002 GLU A 1011 1 10 HELIX 14 AB5 SER A 1038 GLY A 1051 1 14 HELIX 15 AB6 THR A 1059 ASN A 1081 1 23 HELIX 16 AB7 LEU A 1084 SER A 1090 1 7 HELIX 17 AB8 ASP A 1092 GLY A 1107 1 16 HELIX 18 AB9 GLY A 1107 GLY A 1113 1 7 HELIX 19 AC1 PHE A 1114 GLN A 1123 1 10 HELIX 20 AC2 ARG A 1125 LYS A 1135 1 11 HELIX 21 AC3 SER A 1136 THR A 1142 1 7 HELIX 22 AC4 THR A 1142 GLY A 1156 1 15 HELIX 23 AC5 TRP A 1158 LEU A 225 1 8 HELIX 24 AC6 LEU A 225 CYS A 259 1 35 HELIX 25 AC7 PRO A 266 ILE A 292 1 27 HELIX 26 AC8 ILE A 292 VAL A 307 1 16 SHEET 1 AA1 2 CYS A 71 ALA A 72 0 SHEET 2 AA1 2 VAL A 164 ALA A 165 -1 O VAL A 164 N ALA A 72 SHEET 1 AA2 3 ARG A1014 LYS A1019 0 SHEET 2 AA2 3 TYR A1025 GLY A1028 -1 O THR A1026 N TYR A1018 SHEET 3 AA2 3 HIS A1031 THR A1034 -1 O LEU A1033 N TYR A1025 SSBOND 1 CYS A 71 CYS A 159 1555 1555 2.04 SSBOND 2 CYS A 74 CYS A 146 1555 1555 2.03 SSBOND 3 CYS A 77 CYS A 166 1555 1555 2.04 SSBOND 4 CYS A 259 CYS A 262 1555 1555 2.03 SITE 1 AC1 20 VAL A 84 LEU A 85 THR A 88 GLN A 89 SITE 2 AC1 20 LEU A 167 PHE A 168 GLU A 169 VAL A 186 SITE 3 AC1 20 TRP A 246 LEU A 249 HIS A 250 ASN A 253 SITE 4 AC1 20 THR A 256 HIS A 264 LEU A 267 MET A 270 SITE 5 AC1 20 TYR A 271 ILE A 274 SER A 277 HIS A 278 SITE 1 AC2 3 GLY A 5 SER A 6 TYR A 271 CRYST1 47.783 78.226 86.477 90.00 101.20 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020928 0.000000 0.004142 0.00000 SCALE2 0.000000 0.012783 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011788 0.00000